Capillary Blood Sampling Devices

Capillary Blood Sampling Devices Market Outlook

The global capillary blood sampling devices market is projected to reach approximately USD 1.2 billion by 2035, expanding at a robust CAGR of about 7.5% during the forecast period from 2025 to 2035. This growth is driven by the rising prevalence of chronic diseases, increasing demand for point-of-care testing, and advancements in medical technology. Moreover, the growing emphasis on minimally invasive procedures and patient-centric healthcare delivery is further propelling market growth. The convenience and efficiency offered by capillary blood sampling devices are also significant factors contributing to market expansion, as they allow for quick and accurate blood collection in a range of settings.

Growth Factor of the Market

The capillary blood sampling devices market is significantly influenced by several growth factors that underline the need for efficient and precise blood collection methods. First and foremost, the rise in the incidence of diabetes and other chronic diseases has intensified the need for regular monitoring, thereby increasing demand for capillary blood sampling devices. Additionally, advancements in technology and innovation in product design are contributing to the development of user-friendly and efficient devices that attract healthcare providers and patients alike. Furthermore, the increasing focus on preventive healthcare and early diagnosis is pushing healthcare systems to adopt more efficient diagnostic tools, including capillary blood sampling devices. The growing trend of home healthcare, especially in the context of COVID-19, is also enhancing the appeal of these devices, as they enable patients to self-monitor their health in a non-invasive manner. Lastly, favorable reimbursement policies and regulatory support for innovative healthcare solutions are poised to create a conducive environment for market growth.

Key Highlights of the Market

• Increasing prevalence of chronic diseases such as diabetes and hypertension driving demand for capillary blood sampling devices.
• Technological advancements enhancing the efficiency and user-friendliness of blood sampling devices.
• Growing trend towards home healthcare and self-monitoring among patients.
• Supportive regulatory and reimbursement frameworks promoting innovation in the healthcare sector.
• Rising awareness regarding early diagnosis and preventive healthcare fueling market growth.

By Product Type

Lancets:

Lancets are one of the most commonly used products in capillary blood sampling devices, primarily designed for making small punctures in the skin to obtain blood samples. These devices are favored for their ease of use and ability to minimize pain during the sampling process. The growing emphasis on self-monitoring among diabetes patients has significantly increased the demand for lancets, as they provide a simple and effective means for blood glucose testing. Manufacturers are continuously innovating to create lancets that are safer, more efficient, and offer improved user experience. The introduction of automatic and safety-engineered lancets has further propelled their adoption, leading to significant growth in this segment.

Lancet Holders:

Lancet holders play a crucial role in enhancing the safety and convenience of blood sampling procedures. Designed to hold the lancet securely, these devices ensure that the lancet is used safely and effectively while minimizing the risk of needle-stick injuries. The increasing demand for safety-engineered devices in healthcare settings is driving the growth of this market segment. Additionally, the rising trend of self-sampling among patients has led to a higher need for user-friendly lancet holders that facilitate ease of use. Manufacturers are focusing on developing ergonomic designs and adjustable settings in lancet holders to cater to a broader range of users, reinforcing their market presence.

Blood Collection Tubes:

Blood collection tubes are essential components in the capillary blood sampling process, used for collecting and transporting blood samples for laboratory analysis. With advancements in materials and design, modern blood collection tubes offer enhanced safety features and improved sample integrity. The increasing adoption of point-of-care testing and home healthcare solutions is driving the demand for blood collection tubes that are compatible with various testing methodologies. In particular, the development of micro-volume blood collection tubes is gaining traction, as they allow for the collection of smaller blood samples, making them suitable for a range of diagnostic applications. This segment is expected to witness considerable growth as healthcare providers and patients seek more efficient alternatives.

Blood Collection Microfluidic Devices:

Microfluidic devices represent a cutting-edge approach to blood collection, utilizing advanced technology to manipulate small volumes of fluids for diagnostic purposes. This innovative product type is gaining traction due to its ability to provide rapid results with minimal invasiveness. The increasing emphasis on precision medicine and personalized healthcare is driving interest in microfluidic devices, as they facilitate targeted diagnostics and treatment. Moreover, the integration of microfluidics with digital health technologies is further enhancing their appeal, as these devices can be connected to smartphones and other digital platforms for real-time monitoring. As the market for point-of-care testing expands, microfluidic devices are expected to play a pivotal role in transforming the landscape of capillary blood sampling.

Blood Collection Warming Devices:

Blood collection warming devices are designed to enhance the blood flow in capillary sampling sites, thereby improving the ease and effectiveness of blood collection. These devices are particularly beneficial in situations where patients may have compromised circulation or where blood flow is typically slow, such as in cold weather. The growing awareness regarding the importance of effective blood sampling techniques is driving the demand for warming devices, as they contribute to improved patient comfort and sample quality. Additionally, advancements in warming technology, such as portable and easy-to-use devices, are appealing to healthcare providers and patients alike, thus fostering growth in this product segment.

By Application

Glucose Monitoring:

Glucose monitoring is one of the primary applications of capillary blood sampling devices, particularly for individuals living with diabetes. The need for regular blood glucose testing is crucial for effective diabetes management, and capillary blood sampling devices offer a convenient and minimally invasive solution. The increase in diabetes prevalence and the growing emphasis on self-management are driving the demand for devices that facilitate easy and accurate glucose monitoring. Additionally, advancements in technology, such as smart glucose meters that sync with mobile applications, are enhancing the overall user experience. As healthcare systems continue to promote patient-centered care, the glucose monitoring segment is anticipated to witness robust growth.

Hemoglobin Testing:

Hemoglobin testing represents another critical application in the capillary blood sampling market, utilized primarily for diagnosing anemia and other blood disorders. The increasing awareness of the importance of early diagnosis and management of hemoglobin-related conditions is driving demand for convenient testing solutions. Capillary blood sampling devices allow for quick and efficient hemoglobin testing, particularly in settings such as clinics and homecare. The rise in population health initiatives aimed at screening for anemia, especially in high-risk groups such as pregnant women and children, further bolsters this segment's growth. The integration of portable hemoglobin testing devices is also enhancing accessibility, making it easier for patients and healthcare providers to conduct necessary tests.

Coagulation Testing:

Coagulation testing is essential for evaluating blood clotting disorders and monitoring anticoagulant therapy. Capillary blood sampling devices offer a practical solution for coagulation testing, allowing for easier blood sample collection compared to traditional venipuncture methods. The growing prevalence of blood clotting disorders and the rising number of surgical procedures requiring coagulation monitoring are contributing to the demand for these devices. Furthermore, advancements in point-of-care coagulation testing technologies are making it easier for healthcare providers to perform timely assessments, thereby improving patient outcomes. This segment is expected to continue growing, driven by a focus on improving healthcare quality and reducing treatment delays.

Infectious Disease Testing:

Infectious disease testing is becoming increasingly vital in public health, especially in the context of global health emergencies such as pandemics. Capillary blood sampling devices facilitate rapid and efficient testing for a range of infectious diseases, including HIV, hepatitis, and COVID-19. The convenience of these devices enables healthcare workers to conduct tests in various settings, including remote areas and during mass screening events. The rising global awareness of infectious disease management and the need for quick diagnostic solutions are propelling the growth of this segment. Moreover, the integration of digital health solutions with capillary blood sampling devices is enhancing the speed and accuracy of infectious disease testing, further contributing to this segment's expansion.

Others:

Other applications of capillary blood sampling devices encompass a range of diagnostic tests that do not fall into the previously mentioned categories. This includes tests for various biomarkers and diseases, which are gaining traction due to the increasing need for comprehensive health monitoring. The versatility of capillary sampling devices makes them suitable for various diagnostic applications, which promotes innovation and development within this space. As healthcare providers aim to offer holistic and integrated care, the demand for diverse diagnostic testing methods is expected to grow. This segment is thus positioned to capture a significant share of the market, driven by ongoing technological advancements and the increasing focus on preventive healthcare.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics distribution channel remains a primary avenue for the capillary blood sampling devices market. These healthcare facilities are equipped with a range of medical equipment, including capillary blood sampling devices, that facilitate effective patient care. Hospitals and clinics prioritize high-quality, reliable diagnostic tools, leading to steady demand for these devices. The increasing patient volume and the need for rapid, point-of-care testing are driving investments in advanced blood sampling technologies within these establishments. Additionally, partnerships between manufacturers and hospitals enhance access to innovative devices, thus bolstering this segment's growth prospects.

Homecare Settings:

The homecare settings distribution channel is rapidly gaining momentum as patients increasingly prefer self-monitoring their health conditions. Capillary blood sampling devices are particularly well-suited for homecare, allowing patients to perform tests in the comfort of their homes. This shift towards home-based healthcare solutions is driven by the aging global population and the rising incidence of chronic diseases, prompting the need for continuous monitoring. Manufacturers are focusing on creating user-friendly and safe devices that cater to the homecare market. As healthcare systems promote cost-effective solutions, the homecare segment is expected to witness significant growth as patients seek greater autonomy over their health management.

Diagnostic Centers:

Diagnostic centers are an essential segment of the capillary blood sampling devices market, as they serve as dedicated facilities for performing a range of tests. These centers are equipped with the latest technology and skilled personnel to provide accurate and timely diagnostic results. The demand for capillary blood sampling devices in diagnostic centers is fueled by the rising patient volume and the need for efficient blood testing solutions. Additionally, the increasing adoption of point-of-care testing methodologies is enhancing the role of diagnostic centers in providing rapid results. As healthcare providers seek to optimize diagnostic processes, the diagnostic centers segment is poised for significant growth.

Others:

The "Others" distribution channel encompasses various ancillary avenues for the distribution of capillary blood sampling devices, including retail pharmacies, online platforms, and specialized healthcare suppliers. The growth of e-commerce and the increasing availability of these devices through retail channels are making it easier for patients and healthcare providers to access and purchase capillary blood sampling products. Furthermore, the trend towards personalized healthcare and self-monitoring is driving demand for convenient purchasing options, enhancing this segment's market attractiveness. As the landscape of healthcare evolves, innovative distribution strategies are expected to create new growth opportunities in this sector.

By Material Type

Plastic:

Plastic is one of the dominant materials used in the manufacturing of capillary blood sampling devices, owing to its versatility, light weight, and cost-effectiveness. Plastic devices, such as blood collection tubes and lancets, offer advantages such as durability and ease of disposal. The rising focus on minimizing infection risk and promoting safety in healthcare settings has led to increased adoption of plastic-based devices. Moreover, advancements in plastic manufacturing technologies have enhanced the quality and functionality of these devices, making them suitable for various applications. As manufacturers continue to innovate and improve plastic-based sampling devices, the segment is anticipated to experience significant growth.

Stainless Steel:

Stainless steel is widely regarded as a preferred material for certain capillary blood sampling devices, particularly lancets and needle holders, due to its durability and resistance to corrosion. These attributes make stainless steel devices ideal for healthcare settings where hygiene and safety are paramount. Furthermore, the increasing demand for safety-engineered devices has led to the development of stainless steel lancets with additional safety features. The rising awareness about the importance of infection control in healthcare environments is driving the demand for stainless steel devices, as they can be sterilized and reused, thereby reducing waste. This segment is expected to maintain a steady growth trajectory as healthcare providers continue to prioritize safety in their operations.

Glass:

Glass is another material type used in capillary blood sampling devices, primarily for blood collection tubes. Glass tubes are favored for their inert properties, which ensure that they do not react with blood components and maintain sample integrity. The growing demand for high-quality diagnostic testing is fostering the use of glass-based devices, especially in laboratory settings where precision is essential. Additionally, advancements in glass manufacturing techniques have led to the production of lightweight and robust glass tubes that enhance usability. Although the market for glass devices is relatively smaller compared to plastic, it remains crucial due to the specific applications that require glass's unique properties.

Others:

The "Others" category encompasses various alternative materials used in capillary blood sampling devices, including biodegradable materials and composite materials that aim to enhance safety and performance. The increasing focus on sustainability in healthcare is driving interest in environmentally friendly materials that reduce the ecological footprint of medical waste. As manufacturers explore innovative materials that offer improved functionality and reduce environmental impact, this segment is expected to grow. The rising demand for advanced materials in healthcare applications is likely to create new opportunities for research and development, propelling further advancements in the capillary blood sampling devices market.

By Region

The global capillary blood sampling devices market demonstrates significant regional disparities, with North America being a prominent market. Valued at approximately USD 450 million in 2024, this region is expected to grow at a CAGR of 8% over the forecast period, driven by the strong presence of established healthcare systems, increasing adoption of point-of-care testing, and the high prevalence of chronic diseases. The growing emphasis on preventive healthcare and advancements in medical technologies are further bolstering the demand for capillary blood sampling devices in North America. Additionally, the rise in diabetes and infectious disease testing initiatives is propelling market growth, thereby solidifying North America's position as a leader in the capillary blood sampling devices market.

Europe is another significant regional market for capillary blood sampling devices, holding an estimated market value of around USD 350 million in 2024. The region is predicted to witness steady growth due to the increasing demand for advanced healthcare solutions and the rising incidence of chronic diseases. The focus on patient-centric care and the growing trend towards home healthcare solutions are driving the need for convenient blood sampling devices. Additionally, the presence of numerous key players in the healthcare market, along with ongoing research and development initiatives, is expected to bolster the growth of the capillary blood sampling devices market in Europe. Meanwhile, the Asia Pacific region is anticipated to emerge as a lucrative market due to the rising population, increasing healthcare expenditure, and advancements in healthcare infrastructure.

Opportunities

The capillary blood sampling devices market is ripe with opportunities that can be leveraged by manufacturers and healthcare providers alike. One of the most significant growth opportunities lies in the expansion of point-of-care testing, driven by the increasing emphasis on decentralized healthcare and immediate diagnostic capabilities. As healthcare systems shift towards patient-centric models, the demand for devices that facilitate rapid testing in various environments will continue to soar. Furthermore, innovations in digital health technologies, such as mobile applications and connectivity features, are creating new avenues for integrating blood sampling devices with telehealth solutions. This integration can enhance patient engagement and provide real-time health monitoring, ultimately improving health outcomes and creating a robust market for capillary blood sampling devices.

Another key opportunity in this market is the rising trend of personalized medicine and preventive healthcare. Patients are increasingly seeking tailored health solutions, and capillary blood sampling devices can play a crucial role in enabling frequent monitoring of various health parameters. The ability to offer at-home testing solutions, particularly in the context of chronic diseases, presents a significant opportunity for manufacturers to develop innovative products that cater to patient preferences. Additionally, partnerships with healthcare professionals and organizations can lead to enhanced product visibility and adoption. By focusing on developing user-friendly, reliable, and safe blood sampling devices, manufacturers can position themselves to capitalize on this growing market opportunity.

Threats

The capillary blood sampling devices market faces several threats that could impact growth and development. One of the primary threats is the increasing competition from alternative blood sampling methods, such as venipuncture and emerging non-invasive technologies. As these methods continue to evolve, there is a risk that they may overshadow capillary blood sampling devices, particularly in settings that prioritize traditional approaches. Additionally, stringent regulatory requirements surrounding the approval and commercialization of medical devices can pose challenges for manufacturers seeking to bring innovative products to market. Navigating the complex regulatory landscape requires significant resources and can lead to delays in product launches, which may hinder market growth.

Another critical threat to the capillary blood sampling devices market is the potential for safety concerns and adverse events associated with device usage. Reports of needle-stick injuries or improper use of sampling devices can lead to negative perceptions and reduced acceptance among healthcare professionals and patients. This underscores the importance of implementing robust safety features and providing extensive user training to mitigate these risks. Furthermore, fluctuations in raw material costs, particularly for plastic and stainless steel, can impact production costs and profit margins for manufacturers. Addressing these threats will require continuous innovation, diligent regulatory compliance, and a commitment to safety and quality across the industry.

Competitor Outlook

• Roche Diagnostics
• BD (Becton, Dickinson and Company)
• Abbott Laboratories
• Terumo Corporation
• Greiner Bio-One International GmbH
• Medtronic
• F. Hoffmann-La Roche AG
• GlucoLab
• HTL-Strefa S.A.
• Siemens Healthineers
• Accu-Chek (Roche)
• LifeScan (Johnson & Johnson)
• HemoCue
• Nova Biomedical
• Trinity Biotech

The competitive landscape of the capillary blood sampling devices market is characterized by the presence of several established players and emerging companies striving to capture market share. Key players such as Roche Diagnostics and BD (Becton, Dickinson and Company) have long been industry leaders, leveraging their extensive product portfolios and innovative technologies to maintain a competitive edge. These companies invest heavily in research and development to introduce advanced capillary blood sampling devices that meet the evolving needs of healthcare providers and patients. Furthermore, partnerships and collaborations among manufacturers and healthcare organizations are becoming prevalent as companies seek to expand their reach and enhance product visibility in the market.

In addition to established players, several emerging and mid-sized companies are making their presence felt in the capillary blood sampling devices market. For instance, companies like Greiner Bio-One International and Terumo Corporation are focusing on developing innovative product designs to meet the growing demand for safety-engineered devices. These companies are capitalizing on niche segments, such as microfluidic devices and automated lancets, to differentiate themselves from larger competitors. Moreover, the increasing trend of personalized healthcare is prompting manufacturers to invest in tailored solutions that cater to specific patient needs, thereby enhancing their competitive positioning in the market.

Major companies such as Abbott Laboratories, Medtronic, and Siemens Healthineers are also making strides in the capillary blood sampling devices market by integrating digital health technologies with their product offerings. The incorporation of mobile applications and connectivity features is allowing these companies to provide comprehensive health monitoring solutions that resonate with patients and healthcare providers. As the market continues to evolve, the competition is expected to intensify, with companies focusing on innovation, quality, and customer-centric approaches to capture a larger share of the growing capillary blood sampling devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HemoCue
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GlucoLab
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 HTL-Strefa S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Nova Biomedical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Trinity Biotech
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Accu-Chek (Roche)
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Siemens Healthineers
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 F. Hoffmann-La Roche AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 LifeScan (Johnson & Johnson)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Greiner Bio-One International GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Capillary Blood Sampling Devices Market, By Application
    • 6.1.1 Glucose Monitoring
    • 6.1.2 Hemoglobin Testing
    • 6.1.3 Coagulation Testing
    • 6.1.4 Infectious Disease Testing
    • 6.1.5 Others
  • 6.2 Capillary Blood Sampling Devices Market, By Product Type
    • 6.2.1 Lancets
    • 6.2.2 Lancet Holders
    • 6.2.3 Blood Collection Tubes
    • 6.2.4 Blood Collection Microfluidic Devices
    • 6.2.5 Blood Collection Warming Devices
  • 6.3 Capillary Blood Sampling Devices Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Stainless Steel
    • 6.3.3 Glass
    • 6.3.4 Others
  • 6.4 Capillary Blood Sampling Devices Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Homecare Settings
    • 6.4.3 Diagnostic Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Capillary Blood Sampling Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Capillary Blood Sampling Devices market is categorized based on

By Product Type

• Lancets
• Lancet Holders
• Blood Collection Tubes
• Blood Collection Microfluidic Devices
• Blood Collection Warming Devices

By Application

• Glucose Monitoring
• Hemoglobin Testing
• Coagulation Testing
• Infectious Disease Testing
• Others

By Distribution Channel

• Hospitals & Clinics
• Homecare Settings
• Diagnostic Centers
• Others

By Material Type

• Plastic
• Stainless Steel
• Glass
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Roche Diagnostics
• BD (Becton, Dickinson and Company)
• Abbott Laboratories
• Terumo Corporation
• Greiner Bio-One International GmbH
• Medtronic
• F. Hoffmann-La Roche AG
• GlucoLab
• HTL-Strefa S.A.
• Siemens Healthineers
• Accu-Chek (Roche)
• LifeScan (Johnson & Johnson)
• HemoCue
• Nova Biomedical
• Trinity Biotech